NovaSterilis

NovaSterilis NovaSterilis uses supercritical CO2 solutions to promote safe, innovative products and improve lives.

NovaSterilis is the global leader in the development and manufacturing of supercritical carbon dioxide (scCO2) processes for biomaterials and medical devices, including the decellularization and sterilization of allograft and xenograft tissues. At its core, NovaSterilis is a team of scientists, engineers, and business people committed to meeting our customers' needs through problem-solving. Our mu

lti-disciplinary team of engineers, biochemists, and molecular and cellular biologists bring their broad and deep knowledge to every development challenge. We have the team, equipment, and processes readily available to provide scCO2 solutions that enable the implementation of manufacturing solutions that meet product safety requirements and performance and enable our partners to deliver safe, innovative products that advance patient healing and outcomes. With NovaSterilis you can count on a sterility assurance level 10-6, an environmentally friendly solution, shorter turnaround times, and more. Protect and differentiate your products with supercritical CO2.

Contamination control is critical for successful R&D experiments, and the right equipment can make all the difference....
09/03/2026

Contamination control is critical for successful R&D experiments, and the right equipment can make all the difference.

Discover how to protect your research with in-lab sterilization that’s efficient, repeatable, and built for innovation: https://bit.ly/3Bk6t4l

09/02/2026

By the time this paper was published in 2015, had already been demonstrated to be effective for sterilizing tissue products, but how does scCO2 actually stack up when compared to gamma and e-beam?

Read more:

This white paper evaluates sterilization of amniotic fluid and cytokine preservation.Analysis shows conservation of mo...
09/01/2026

This white paper evaluates sterilization of amniotic fluid and cytokine preservation.

Analysis shows conservation of most proteins following scCO2 processing.

The study examines performance alongside retention of native cytokine content. Read more: https://bit.ly/4c2gema

With the 35th Annual Conference of the European Society for Biomaterials happening next week, innovation is at the cente...
08/31/2026

With the 35th Annual Conference of the European Society for Biomaterials happening next week, innovation is at the center of the conversation.

As researchers develop increasingly advanced materials for medical devices and regenerative medicine, sterilization becomes a critical consideration. The right approach must achieve sterility without compromising material properties or performance.

NovaSterilis is advancing sterilization to help expand what’s possible for sensitive biomaterials.

Conventional decellularization can require days or weeks of detergent washing.Our new article examines as an alternati...
08/27/2026

Conventional decellularization can require days or weeks of detergent washing.

Our new article examines as an alternative for decellularization, cleaning, and sterilization.

We show how NovaSterilis’ cartilage process achieved decellularization in 12 hours and 2.5-day total processing.

Explore the workflow differences and implications for regenerative medicine research: https://bit.ly/3Ssf6CA

08/25/2026

See how rapidly dissolves in within minutes!

Supercritical CO2 and NovaKill readily form a homogeneous mixture with synergistic properties that achieve terminal sterilization.

This behavior highlights how additive levels and introduction methods can be tuned through cycle parameters to fit the needs of each product.

These dynamics enable across products with varying requirements.

offers distinct advantages for sterilizing sensitive materials.It achieves SAL 10-6 while supporting broad material an...
08/24/2026

offers distinct advantages for sterilizing sensitive materials.

It achieves SAL 10-6 while supporting broad material and biologic compatibility.

Controlled processing also helps preserve physical, mechanical, and biochemical material properties.

Explore what differentiates scCO2 from conventional sterilization modalities: https://bit.ly/4fSQY43

Biofilms remain a significant sterilization challenge for reusable with complex geometries. with NovaKill additive a...
08/20/2026

Biofilms remain a significant sterilization challenge for reusable with complex geometries.

with NovaKill additive achieved complete eradication of mature S. aureus and P. aeruginosa biofilms in this study.

Download our white paper to learn more and review the data: https://bit.ly/3pIBuJI

Regulatory acceptance of sterilization continues to expand across global markets. Medical devices sterilized with scCO...
08/19/2026

Regulatory acceptance of sterilization continues to expand across global markets.

Medical devices sterilized with scCO2 have progressed through FDA 510(k), TGA, and European regulatory pathways while aligning with ISO 14937 and ISO 11138.

Preserving collagen structure and growth factor activity is critical for implantable . methods can directly influence...
08/18/2026

Preserving collagen structure and growth factor activity is critical for implantable .

methods can directly influence tissue performance, mechanical integrity, and clinical outcomes.

Explore recent findings on biomaterial preservation with sterilization: https://bit.ly/4iFQFJ5

Address

3109 North Triphammer Terrace
Lansing, NY
14882

Website

Alerts

Be the first to know and let us send you an email when NovaSterilis posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to NovaSterilis:

Shortcuts

Share

Category